HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Arturo Casadevall Selected Research

Virulence Factors (Pathogenicity Factors)

11/2021How does temperature trigger biofilm adhesion and growth in Candida albicans and two non-Candida albicans Candida species?
10/2016Extracellular vesicles from Paracoccidioides brasiliensis induced M1 polarization in vitro.
8/2015Lipid Biosynthetic Genes Affect Candida albicans Extracellular Vesicle Morphology, Cargo, and Immunostimulatory Properties.
6/2014Capsule growth in Cryptococcus neoformans is coordinated with cell cycle progression.
1/2014Molecular determinants for a cardiovascular collapse in anthrax.
4/2013Fungal virulence in a lepidopteran model is an emergent property with deterministic features.
7/2011Role for Golgi reassembly and stacking protein (GRASP) in polysaccharide secretion and fungal virulence.
6/2011The F-Box protein Fbp1 regulates sexual reproduction and virulence in Cryptococcus neoformans.
1/2009Virulence factors and their mechanisms of action: the view from a damage-response framework.
9/2008Passive administration of monoclonal antibodies to anthrolysin O prolong survival in mice lethally infected with Bacillus anthracis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Arturo Casadevall Research Topics

Disease

93Infections
01/2022 - 08/2001
40COVID-19
11/2022 - 01/2020
29Cryptococcosis
01/2020 - 03/2002
26Communicable Diseases (Infectious Diseases)
05/2022 - 09/2003
25Mycoses (Diseases, Fungus)
01/2021 - 09/2002
25Neoplasms (Cancer)
01/2020 - 10/2004
21Tuberculosis (Tuberculoses)
01/2019 - 05/2002
10Anthrax
01/2020 - 08/2002
10Melanoma (Melanoma, Malignant)
04/2013 - 10/2004
8Inflammation (Inflammations)
01/2022 - 03/2002
6Starvation
01/2020 - 10/2008
4Persistent Infection
08/2012 - 11/2005
3Disease Progression
05/2022 - 08/2010
3Meningoencephalitis
01/2022 - 06/2015
3Autoimmune Diseases (Autoimmune Disease)
01/2019 - 01/2017
3Histoplasmosis
01/2019 - 09/2002
3Pneumonia (Pneumonitis)
01/2019 - 04/2002
3Shock
03/2014 - 05/2008
3Experimental Melanoma
02/2013 - 04/2006
3Edema (Dropsy)
11/2010 - 09/2008
2Respiratory Tract Diseases (Respiratory Tract Disease)
01/2021 - 03/2010
2Meningitis
01/2019 - 09/2005
2Hypoxia (Hypoxemia)
01/2018 - 03/2015
2Polyploidy
01/2018 - 01/2017
2Pancreatic Neoplasms (Pancreatic Cancer)
03/2017 - 05/2013
2Cryptococcal Meningitis
01/2017 - 03/2005
2Rheumatoid Arthritis
01/2014 - 01/2013
2Fungal Meningitis
12/2013 - 02/2013
2Candidiasis (Moniliasis)
08/2012 - 01/2006
2Virus Diseases (Viral Diseases)
01/2011 - 09/2007
2Uterine Cervical Neoplasms (Cancer of the Cervix)
02/2010 - 10/2007
1Breakthrough Infections
05/2022

Drug/Important Bio-Agent (IBA)

44AntibodiesIBA
01/2022 - 08/2002
28Monoclonal AntibodiesIBA
11/2022 - 03/2002
27Polysaccharides (Glycans)IBA
01/2019 - 08/2001
24Melanins (Melanin)IBA
01/2022 - 08/2001
23VaccinesIBA
03/2022 - 10/2003
17AntigensIBA
01/2020 - 10/2003
17Capsules (Microcapsules)IBA
11/2019 - 08/2001
16Immunoglobulin G (IgG)IBA
03/2022 - 05/2002
15Proteins (Proteins, Gene)FDA Link
11/2022 - 01/2003
14Virulence Factors (Pathogenicity Factors)IBA
11/2021 - 09/2002
9Pharmaceutical PreparationsIBA
01/2020 - 06/2004
8Neutralizing AntibodiesIBA
05/2022 - 07/2008
8EpitopesIBA
01/2022 - 08/2001
8Peptides (Polypeptides)IBA
01/2021 - 04/2006
7CytokinesIBA
02/2021 - 03/2002
7Immunoglobulin M (IgM)IBA
01/2019 - 03/2003
6Radioisotopes (Radionuclides)IBA
03/2009 - 08/2005
5Antiviral Agents (Antivirals)IBA
05/2022 - 05/2007
5LipidsIBA
10/2020 - 03/2014
5Biological ProductsIBA
07/2020 - 08/2007
5EnzymesIBA
11/2019 - 01/2003
5Immunoglobulins (Immunoglobulin)IBA
04/2013 - 05/2002
5Viral AntigensIBA
02/2011 - 06/2007
4Biomarkers (Surrogate Marker)IBA
01/2021 - 02/2012
4Carrier Proteins (Binding Protein)IBA
01/2019 - 09/2009
4Amphotericin B (Amphotericin)FDA LinkGeneric
01/2017 - 10/2005
4galactoxylomannanIBA
01/2013 - 05/2007
3CatecholaminesIBA
01/2022 - 07/2011
3Anti-Bacterial Agents (Antibiotics)IBA
12/2020 - 12/2009
3Anti-Infective Agents (Microbicides)IBA
01/2020 - 11/2005
3Therapeutic UsesIBA
03/2017 - 10/2004
3Oncogene Proteins (Oncogene Protein)IBA
02/2011 - 02/2010
3Proteasome InhibitorsIBA
11/2010 - 02/2010
3Biological Warfare AgentsIBA
10/2008 - 09/2004
3glucuronoxylomannanIBA
06/2007 - 08/2001
3Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
02/2005 - 04/2002
2Interleukin-4 (Interleukin 4)IBA
01/2022 - 04/2005
2ChemokinesIBA
02/2021 - 11/2005
2Antigen-Antibody Complex (Immune Complex)IBA
01/2021 - 03/2008
2Amino AcidsFDA Link
01/2021 - 11/2007
2Glycoproteins (Glycoprotein)IBA
01/2019 - 06/2007
2Blood Proteins (Serum Proteins)IBA
01/2019 - 01/2018
2Galectin 3 (LGALS3)IBA
01/2019 - 12/2017
2Catalytic AntibodiesIBA
01/2017 - 01/2017
2Fluconazole (Zonal)FDA LinkGeneric
01/2017 - 04/2006
2Detergents (Detergent)IBA
01/2016 - 05/2002
2BCG VaccineFDA Link
01/2016 - 09/2014
2Interleukin-10 (Interleukin 10)IBA
03/2015 - 03/2008
2Nitric Oxide Synthase (NO Synthase)IBA
06/2013 - 04/2002
2Nitric Oxide (Nitrogen Monoxide)FDA Link
06/2013 - 04/2002
2Complement System Proteins (Complement)IBA
04/2013 - 05/2002
2benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA
11/2010 - 02/2010
2Interleukin-12 (IL 12)IBA
03/2008 - 04/2006
2Viral ProteinsIBA
10/2007 - 06/2007
2Immunoglobulin Fab FragmentsIBA
09/2007 - 12/2006
2Immunoglobulin E (IgE)IBA
06/2007 - 04/2006
2Voriconazole (Vfend)FDA LinkGeneric
08/2006 - 06/2004
2Interferon-gamma (Interferon, gamma)IBA
04/2006 - 02/2005
2LaccaseIBA
05/2005 - 04/2005
1N-methyl-valyl-amiclenomycin (BA 2)IBA
05/2022

Therapy/Procedure

53Therapeutics
05/2022 - 09/2003
24Radioimmunotherapy
12/2014 - 11/2005
4Drug Therapy (Chemotherapy)
01/2021 - 04/2009
3Immunotherapy
12/2017 - 08/2009
2Complementary Therapies (Alternative Medicine)
01/2022 - 05/2013
2Artificial Respiration (Mechanical Ventilation)
01/2021 - 08/2020
2Catheters
03/2015 - 02/2010
2Injections
12/2013 - 02/2013